GRDNGuardian Pharmacy Services, Inc.

HealthcareUSD
$37.49

Price

$37.49+83%1Y
1M-4.8%1Y+83%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Average
6/10
Value26
Quality82
Momentum70
Growth38
Strongest Quality, weakest Value · ranked vs Healthcare peers. The five questions below judge the company on its own terms.
What they do

We are a leading, highly differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. We emphasize high-touch, individualized clinical, drug dispensing and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as assisted living facilities (“ALFs”), and behavioral health facilities and group homes (collectively “BHFs”).

In the company’s own words · 10-K filed Mar 11, 2026 · SEC EDGAR

P/E (TTM)-
Market Cap$2.69B
1Y Return+83%
5Y Return-

Guardian Pharmacy Services, Inc. (GRDN) reported revenue of $352M in Q2 2026 (quarter ended June 30, 2026), up 2.2% from the same quarter a year earlier. That came with a gross margin of 23% and net income of $22M (6.2% of revenue). For the full year FY2025, revenue was $1.45B (+18% year on year) and net income $49M.

Raw charts

8 series · TTM

As reported to the SEC, without any scoring.

Medical Care Facilities

Ranks #24 of 28 by Smart Score

Compare peers
ACHC+5.1%
Acadia Healthcare Company, Inc.
PIII-4.1%
P3 Health Partners Inc.
ASTH+2.9%
Astrana Health, Inc.
SGRY+1.6%
Surgery Partners, Inc.
MD-0.45%
Pediatrix Medical Group, Inc.
NHC-0.63%
National HealthCare Corporation